QQ客服 官方微博 反馈留言

	Efficacy and safety analysis of new P2Y(12) inhibitors versus clopidogrel in patients with percutaneous coronary intervention: a meta-analysis
	Gan, Xue-Dong; Wei, Bao-Zhu; Fang, Dong; Fang, Qi; Li, Kai-Yong; Ding, Shi-Lan-Ying; Peng, Song; Wan, Jing
刊名	CURRENT MEDICAL RESEARCH AND OPINION
	2015
卷号	31期号:12
关键词	Acute coronary syndrome Clopidogrel Meta-analysis New P2Y(12) inhibitors Percutaneous coronary intervention Randomized clinical trial
ISSN号	0300-7995
DOI	10.1185/03007995.2015.1098600
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3890540
专题	武汉大学
推荐引用方式 GB/T 7714	Gan, Xue-Dong,Wei, Bao-Zhu,Fang, Dong,et al. Efficacy and safety analysis of new P2Y(12) inhibitors versus clopidogrel in patients with percutaneous coronary intervention: a meta-analysis[J]. CURRENT MEDICAL RESEARCH AND OPINION,2015,31(12).
APA	Gan, Xue-Dong.,Wei, Bao-Zhu.,Fang, Dong.,Fang, Qi.,Li, Kai-Yong.,...&Wan, Jing.(2015).Efficacy and safety analysis of new P2Y(12) inhibitors versus clopidogrel in patients with percutaneous coronary intervention: a meta-analysis.CURRENT MEDICAL RESEARCH AND OPINION,31(12).
MLA	Gan, Xue-Dong,et al."Efficacy and safety analysis of new P2Y(12) inhibitors versus clopidogrel in patients with percutaneous coronary intervention: a meta-analysis".CURRENT MEDICAL RESEARCH AND OPINION 31.12(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。